Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.5100
0.00 (0.00%)
Oct 24, 2025, 3:47 PM EDT
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $2.36 million as of October 24, 2025. Its market cap has decreased by -28.92% in one year.
Market Cap
2.36M
Enterprise Value
-151.11K
Revenue
470.16K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.51
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 2.36M, a decrease of -91.29%. That is a compound annual growth rate of -57.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 2.36M | -36.10% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 618.32M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 342.45M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.35M |
| American Oncology Network | 297.14M |